✓ No loaded language, vague sourcing, or framing detected.
The FDA has granted approval for Moderna's mRNA influenza vaccine. This new method is designed to allow countries to choose the most effective flu strain for their specific needs, moving away from the traditional method of targeting one strain per hemisphere.
Our neutral summary
The FDA has granted approval for Moderna's mRNA influenza vaccine. This new method is designed to allow countries to choose the most effective flu strain for their specific needs, moving away from the traditional method of targeting one strain per hemisphere.
The reporting belongs to New York Times — Politics; we don't reproduce it.
No note attached
on this article.
F.D.A. Approves Moderna’s mRNA Flu Vaccine
FDA Approves Moderna's mRNA Influenza Vaccine